{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:34:28Z","timestamp":1789043668507,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jtct.2023.04.014","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T21:57:31Z","timestamp":1682200651000},"page":"506.e1-506.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3714","authenticated-orcid":false,"given":"Alida","family":"Dominietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Vagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"di Grazia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bregante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Raiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Varaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gualandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gusinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvina","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.04.014_bib0001","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/s41409-019-0465-9","article-title":"The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies","volume":"54","author":"Passweg","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0002","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.04.014_bib0003","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.17426","article-title":"Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia","volume":"193","author":"Kharfan-Dabaja","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.08.008","article-title":"Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis","volume":"28","author":"Kharfan-Dabaja","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.04.014_bib0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hon.2995","article-title":"Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed\/refractory acute myeloid leukemia: a unicentric retrospective analysis","volume":"40","author":"Shumilov","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12185-022-03377-x","article-title":"Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation","volume":"116","author":"Tachibana","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41409-019-0584-3","article-title":"What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia?","volume":"55","author":"Moukalled","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0008","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0009","doi-asserted-by":"crossref","first-page":"368.e1","DOI":"10.1016\/j.jtct.2022.03.025","article-title":"Total marrow and lymphoid irradiation with post-transplantation cyclophosphamide for patients with AML in remission","volume":"28","author":"Stein","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.04.014_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/bloodadvances.2022007530","article-title":"A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT","volume":"7","author":"Tran","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.04.014_bib0011","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.jtct.2023.04.014_bib0012","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2011.01.016","article-title":"Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant","volume":"98","author":"Corv\u00f2","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0013","article-title":"Target coverage and normal organ sparing in dose-escalated total marrow and lymphatic irradiation: a single-institution experience","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0014","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00066-006-1528-6","article-title":"Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation","volume":"182","author":"Kal","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0016","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0017","series-title":"Total Marrow Irradiation","first-page":"69","article-title":"Dose escalation of total marrow and lymphoid irradiation in advanced acute leukemia","author":"Stein","year":"2020"},{"key":"10.1016\/j.jtct.2023.04.014_bib0018","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose escalation of total marrow irradiation in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.meddos.2011.12.001","article-title":"Advances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction technique","volume":"37","author":"Zeverino","year":"2012","journal-title":"Med Dosim"},{"key":"10.1016\/j.jtct.2023.04.014_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2019.07.010","article-title":"Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: a global health initiative by the International Consortium of Total Marrow Irradiation","volume":"141","author":"Zuro","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0021","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.014_bib0022","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.radonc.2017.07.018","article-title":"Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents","volume":"124","author":"Hui","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0023","series-title":"Total Marrow Irradiation","first-page":"89","article-title":"Total marrow irradiation and total lymphoid irradiation in lymphoma and advanced hematologic malignancies: the Genoa experience","author":"Dominietto","year":"2020"},{"key":"10.1016\/j.jtct.2023.04.014_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0026","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbmt.2010.10.003","article-title":"Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation","volume":"17","author":"Coppoletta","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0027","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.04.014_bib0028","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0029","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0360-3016(94)90320-4","article-title":"Radiobiological features of acute myeloblastic leukemia: comparison of self-renewal versus terminally differentiated populations","volume":"30","author":"Cowen","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2023.04.014_bib0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.15973","article-title":"Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"186","author":"Nagler","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0031","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.beha.2016.10.011","article-title":"The role of second transplants for leukemia","volume":"29","author":"Weisdorf","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2023.04.014_bib0032","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2014.11.007","article-title":"Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research study","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0033","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/bmt.2015.186","article-title":"Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT","volume":"50","author":"Ruutu","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.04.014_bib0034","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.04.014_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijrobp.2018.06.015","article-title":"Single-dose daily fractionation is not inferior to twice-a-day fractionated total-body irradiation before allogeneic stem cell transplantation for acute leukemia: a useful practice simplification resulting from the SARASIN study","volume":"102","author":"Belkacemi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723012460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:40Z","timestamp":1763003440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723012460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2666636723012460"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.04.014","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}